MedPath

河南比福制药股份有限公司

Ownership
-
Established
2020-03-12
Employees
-
Market Cap
-
Website
bifu.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

13

NMPA:13

Drug Approvals

Tadalafil Tablets

Product Name
他达拉非片
Approval Number
国药准字H20258067
Approval Date
Apr 21, 2025
NMPA

Azithromycin for Suspension

Product Name
阿奇霉素干混悬剂
Approval Number
国药准字H20249812
Approval Date
Dec 25, 2024
NMPA

Montelukast Sodium Tablets

Product Name
孟鲁司特钠片
Approval Number
国药准字H20249269
Approval Date
Nov 5, 2024
NMPA

Hydrotalcite Chewable Tablets

Product Name
铝碳酸镁咀嚼片
Approval Number
国药准字H20249003
Approval Date
Sep 26, 2024
NMPA

Glucosamine Sulfate Capsules

Product Name
硫酸氨基葡萄糖胶囊
Approval Number
国药准字H20244709
Approval Date
Aug 20, 2024
NMPA

Metoprolol Tartrate Tablets

Product Name
酒石酸美托洛尔片
Approval Number
国药准字H20244503
Approval Date
Jul 30, 2024
NMPA

Metoprolol Tartrate Tablets

Product Name
酒石酸美托洛尔片
Approval Number
国药准字H20244504
Approval Date
Jul 30, 2024
NMPA

Tadalafil Tablets

Product Name
他达拉非片
Approval Number
国药准字H20243994
Approval Date
Jun 11, 2024
NMPA

胃复片

Approval Number
国药准字Z20090093
Approval Date
Jan 23, 2024
NMPA

Levofloxacin Tablets

Product Name
左氧氟沙星片
Approval Number
国药准字H20233731
Approval Date
Jun 14, 2023
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.